CIM
HAE icon

CIM Investment Management’s Haemonetics HAE Stock Holding History

CIM Investment Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$450K Buy
+6,003
New +$386K 0.11% 153
2020
Q2 		– Sell
-3,298
Closed -$329K – 260
2020
Q1 		$329K Buy
3,298
+924
+39% +$100K 0.16% 127
2019
Q4 		$273K Buy
2,374
+155
+7% +$18.8K 0.11% 167
2019
Q3 		$280K Buy
+2,219
New +$282K 0.1% 247
2019
Q2 		– Sell
-8,038
Closed -$703K – 328
2019
Q1 		$703K Buy
8,038
+1,721
+27% +$157K 0.27% 76
2018
Q4 		$632K Buy
6,317
+1,564
+33% +$164K 0.27% 74
2018
Q3 		$545K Buy
+4,753
New +$492K 0.19% 136

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIM Investment Management's HAE Position: Q2 2026 in Review

CIM Investment Management opened a new position in Haemonetics (HAE) in Q2 2026: 6,003 shares worth $450K. The stake represents 0.11% of the portfolio and ranks #153 among its holdings. This is a return to the name: CIM Investment Management previously reported a position in HAE as recently as Q1 2020.

CIM Investment Management first reported a position in HAE in Q3 2018 and has held it in 7 quarters since. The position peaked at $703K in Q1 2019. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • CIM Investment Management held 6,003 shares of Haemonetics worth $450K as of Q2 2026.
  • Haemonetics was a new CIM Investment Management position in Q2 2026.
  • Haemonetics made up 0.11% of CIM Investment Management's portfolio in Q2 2026, its #153 holding.
  • CIM Investment Management first reported a position in Haemonetics in Q3 2018 and has held it in 7 quarters since.
  • CIM Investment Management's Haemonetics position peaked at $703K in Q1 2019.
  • 330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on CIM Investment Management's 13F filing for Q2 2026, filed 29 Sep 2026.